We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cpex Pharmaceuticals, Inc. (MM) | NASDAQ:CPEX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 27.29 | 0 | 00:00:00 |
NAME OF REPORTING PERSON
|
|
1.
|
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
The Mangrove Partners Fund, L.P.
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
x
|
|
(b)
¨
|
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS
|
WC, OO
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
¨
|
6.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Delaware
|
NUMBER OF
|
7
|
SOLE VOTING POWER - 0
|
SHARES
|
||
BENEFICIALLY
|
8
|
SHARED VOTING POWER - 149,373
|
OWNED BY
|
||
EACH
|
9
|
SOLE DISPOSITIVE POWER - 0
|
REPORTING
|
||
PERSON WITH
|
10
|
SHARED DISPOSITIVE POWER - 149,373
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
149,373
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
5.7%*
|
|
14
|
TYPE OF REPORTING PERSON
|
PN
|
1
|
NAME OF REPORTING PERSON
|
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
|
Mangrove Partners
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
x
|
|
(b)
¨
|
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS
|
AF
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Cayman Islands
|
NUMBER OF
|
7
|
SOLE VOTING POWER - 0
|
SHARES
|
||
BENEFICIALLY
|
8
|
SHARED VOTING POWER - 149,373
|
OWNED BY
|
||
EACH
|
9
|
SOLE DISPOSITIVE POWER - 0
|
REPORTING
|
||
PERSON WITH
|
10
|
SHARED DISPOSITIVE POWER - 149,373
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
149,373
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
5.7%*
|
|
14
|
TYPE OF REPORTING PERSON
|
OO
|
1
|
NAME OF REPORTING PERSON
|
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
|
Mangrove Capital
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
x
|
|
(b)
¨
|
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS
|
AF
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Cayman Islands
|
NUMBER OF
|
7
|
SOLE VOTING POWER - 0
|
SHARES
|
||
BENEFICIALLY
|
8
|
SHARED VOTING POWER - 149,373
|
OWNED BY
|
||
EACH
|
9
|
SOLE DISPOSITIVE POWER - 0
|
REPORTING
|
||
PERSON WITH
|
10
|
SHARED DISPOSITIVE POWER - 149,373
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
149,373
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
5.7%*
|
|
14
|
TYPE OF REPORTING PERSON
|
OO
|
1
|
NAME OF REPORTING PERSON
|
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
|
Nathaniel August
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
x
|
|
(b)
¨
|
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS
|
AF
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Cayman Islands
|
NUMBER OF
|
7
|
SOLE VOTING POWER - 0
|
SHARES
|
||
BENEFICIALLY
|
8
|
SHARED VOTING POWER - 149,373
|
OWNED BY
|
||
EACH
|
9
|
SOLE DISPOSITIVE POWER - 0
|
REPORTING
|
||
PERSON WITH
|
10
|
SHARED DISPOSITIVE POWER - 149,373
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
149,373
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
5.7%*
|
|
14
|
TYPE OF REPORTING PERSON
|
IN
|
ITEM 4.
|
Purpose of Transaction.
|
ITEM 7.
|
Material to be Filed as Exhibits.
|
Exhibit No.
|
Document
|
|
99.1
|
Press Release, dated March 21, 2011
|
|
99.2
|
Press Release, dated March 22, 2011
|
THE MANGROVE PARTNERS FUND, L.P.
|
|||
MANGROVE PARTNERS
|
|||
MANGROVE CAPITAL
|
|||
By:
|
/s/ Nathaniel August
|
||
Nathaniel August, for himself, as Director of Mangrove Capital (for itself and The Mangrove Partners Fund, L.P.) and as a Director of Mangrove Partners
|
Exhibit No.
|
Document
|
99.1
|
Press Release, dated March 21, 2011
|
99.2
|
Press Release, dated March 22, 2011
|
1 Year Cpex Pharmaceuticals, Inc. (MM) Chart |
1 Month Cpex Pharmaceuticals, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions